GSK plc GSK announced that the European Medicines Agency (“EMA”) has accepted for review a regulatory filing, seeking approval for a new indication of its respiratory drug, Nucala (mepolizumab).

According to OpenAI, the improved performance is due to specialized pre-training of audio datasets for more nuanced speech understanding, more efficient model distillation techniques, and expanded use ...

“So it’s not just about the use case, but about having the guardrails.” Agents also can be difficult to build and expensive to deploy at scale. Still, enterprises are already reporting ...

Her situation highlights the importance of the Expanded Solo Parents’ Welfare Act (Republic Act 11861). Department of Social Welfare and Development (DSWD) Assistant Secretary Irene Dumlao emphasized ...

Leicester mayor Sir Peter Soulsby has unveiled proposals to expand the city's political boundaries. The Labour politician has proposed a new political map that would see the city's present ...

Steelbook Case 3 Miniature Atari Arcade Marquees 3 Double-Sided Atari 2600 Art Cards Al Alcorn Replica Business Card Slipcase Atari 50: The Anniversary Celebration - Expanded Edition Atari 50 ...

Veronica Escobar (Texas), Jason Crow (Colo.) and John Garamendi (Calif.). “Dramatically expanded use of U.S. military personnel and facilities to support mass detention operations, both ...

US 1h ago Prosecution adds ex-US attorney to University of Idaho quadruple murder case Idaho's recently departed U.S. attorney has joined the prosecution team in the case against Bryan Kohberger ...

Maxwell Lewis' Brooklyn Nets debut was over before it even began. After joining the team in a Dec. 29 trade from the Los Angeles Lakers, the 22-year-old fractured his tibia in the opening minute ...

Fears over China's activity at the Ream base arose in 2019 when The Wall Street Journal reported that an early draft of an agreement seen by U.S. officials would allow China 30-year use of the ...

A final decision from the FDA on mRNA-1283 is expected by May 31. The third regulatory filing seeks expanded use of the mResvia in high-risk adults aged 18-59. A final decision on the mResvia ...